Trials / Conditions / Fibrolamellar Carcinoma

Fibrolamellar Carcinoma

10 registered clinical trials studyying Fibrolamellar Carcinoma — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer NCT06521567	GlaxoSmithKline	Phase 1 / Phase 2
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers NCT06541652	Federation Francophone de Cancerologie Digestive	—
Recruiting	Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Pat NCT05468359	St. Jude Children's Research Hospital	Phase 1 / Phase 2
Suspended	KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) NCT05603572	Primocure Pharma	Phase 1 / Phase 2
Recruiting	Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma NCT04134559	Allison O'Neill, MD	Phase 2
Active Not Recruiting	Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer NCT03860272	Agenus Inc.	Phase 1
Active Not Recruiting	Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Canc NCT03533582	Children's Oncology Group	Phase 3
Completed	Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Canno NCT02159989	National Cancer Institute (NCI)	Phase 1
Completed	Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus NCT01642186	Memorial Sloan Kettering Cancer Center	Phase 2